TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Shareholders Equity (Quarterly) : 69.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.02M |
| March 31, 2026 | 96.92M |
| December 31, 2025 | 123.12M |
| September 30, 2025 | 144.02M |
| June 30, 2025 | 176.71M |
| March 31, 2025 | 210.20M |
| December 31, 2024 | 240.97M |
| September 30, 2024 | 229.09M |
| June 30, 2024 | 255.22M |
| March 31, 2024 | 122.97M |
| December 31, 2023 | 150.87M |
| Date | Value |
|---|---|
| September 30, 2023 | 168.96M |
| June 30, 2023 | 190.61M |
| March 31, 2023 | 78.02M |
| December 31, 2022 | 99.43M |
| September 30, 2022 | 116.66M |
| June 30, 2022 | 131.65M |
| March 31, 2022 | 145.69M |
| December 31, 2021 | 160.78M |
| September 30, 2021 | 174.07M |
| June 30, 2021 | 99.38M |
| March 31, 2021 | 109.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 171.45M |
| Total Liabilities (Quarterly) | 102.43M |
| Debt to Equity Ratio | 1.317 |
| Current Ratio | 3.372 |
| Net Debt Paydown Yield | 1.85% |